...Roche on Friday said it will provide three generic drug companies in sub-Saharan Africa assistance in producing the protease inhibitor saquinavir under its Technology Transfer Initiative (TTI)...The technology transfer for saquinavir - which is recommended by the World Health Organization as a second-line HIV/AIDS treatment in resource-poor countries - is available to drug makers in 63 developing nations...Roche will transfer the technology to South Africa-based Aspen Pharmacare and Kenya-based Cosmos and Universal Corp...Another 25 companies have expressed interest in the TTI.